Abstract
BACKGROUND: Nasal intermittent positive pressure ventilation (NIPPV) is useful in exacerbations of chronic obstructive pulmonary disease (COPD) complicated by ventilatory failure. The effects of NIPPV were compared with those of the respiratory stimulant doxapram on gas exchange in patients with COPD and acute ventilatory failure. METHODS: Patients admitted with acute exacerbations of COPD and type 2 respiratory failure (Pao2 < 8 kPa and PaCO2 > 6.7 kPa) who did not improve with conventional treatment were randomised to receive either NIPPV or intravenous doxapram. Blood gas tensions were monitored for four hours. RESULTS: In nine patients who received NIPPV the arterial PaO2 improved from a mean (SE) of 5.9 (0.4) kPa to a maximum of 8.1 (0.6) kPa which was maintained at four hours. Eight patients who received doxapram had a similar baseline Pao2 of 5.6 (0.4) kPa which rose to a maximum of 7.3 (0.5) kPa but this was not maintained at four hours. The improvement in Pao2 in patients on NIPPV was accompanied by a fall in Paco2 but, in contrast, in those who received doxapram there was no improvement in Paco2. CONCLUSIONS: NIPPV may be more effective than doxapram in the management of acute ventilatory failure complicating COPD.
Full text
PDF
Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- Bott J., Carroll M. P., Conway J. H., Keilty S. E., Ward E. M., Brown A. M., Paul E. A., Elliott M. W., Godfrey R. C., Wedzicha J. A. Randomised controlled trial of nasal ventilation in acute ventilatory failure due to chronic obstructive airways disease. Lancet. 1993 Jun 19;341(8860):1555–1557. doi: 10.1016/0140-6736(93)90696-e. [DOI] [PubMed] [Google Scholar]
- Brochard L., Isabey D., Piquet J., Amaro P., Mancebo J., Messadi A. A., Brun-Buisson C., Rauss A., Lemaire F., Harf A. Reversal of acute exacerbations of chronic obstructive lung disease by inspiratory assistance with a face mask. N Engl J Med. 1990 Nov 29;323(22):1523–1530. doi: 10.1056/NEJM199011293232204. [DOI] [PubMed] [Google Scholar]
- Calverley P. M., Robson R. H., Wraith P. K., Prescott L. F., Flenley D. C. The ventilatory effects of doxapram in normal man. Clin Sci (Lond) 1983 Jul;65(1):65–69. doi: 10.1042/cs0650065. [DOI] [PubMed] [Google Scholar]
- Elliott M. W., Steven M. H., Phillips G. D., Branthwaite M. A. Non-invasive mechanical ventilation for acute respiratory failure. BMJ. 1990 Feb 10;300(6721):358–360. doi: 10.1136/bmj.300.6721.358. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Hirsh K., Wang S. C. Selective respiratory stimulating action of doxapram compared to pentylenetetrazaol. J Pharmacol Exp Ther. 1974 Apr;189(1):1–11. [PubMed] [Google Scholar]
- Jeffrey A. A., Warren P. M., Flenley D. C. Acute hypercapnic respiratory failure in patients with chronic obstructive lung disease: risk factors and use of guidelines for management. Thorax. 1992 Jan;47(1):34–40. doi: 10.1136/thx.47.1.34. [DOI] [PMC free article] [PubMed] [Google Scholar]